Ticker

No recent analyst price targets found for CTTH.

Latest News for CTTH

CTT Pharma Corporate Updates

September 16, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the following corporate actions. Based on a previous announcement for approval of our European patent, CTT has moved forward with a Unitary patent which covers 18 European Union member states.  The company also plans to validate the patent in additional countries which are covered by the Unitary Patent.

TheNewswire • Sep 16, 2026
CTT Pharma Files a Patent Continuation with the U.S. Patent Office

The Newswire – August 18, 2026 - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has filed a patent continuation with the United States Patent Office. This patent application is a continuation of CTT Pharma's micelle patent in the U.S. and introduces additional claims to pursue broader protection. CTT will continue to spend time enhancing it's patent portfolio and will keep shareholders posted on all additional…

TheNewswire • Aug 18, 2026
CTT Pharma Corporate Updates

August 12, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has been looking to acquire a facility for manufacturing and has recently expanded its search for a partnership with a contract manufacturer. CTT is currently engaged in conversations with a contract manufacturer and will update shareholders if an LOI is signed. Additionally, CTT is in advanced contract discussions with an Investor…

TheNewswire • Aug 12, 2026
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology

August 10, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the U.S. Patent Office for a continuation-in-part(CIP). A continuation-in-part (CIP) patent is a new application that repeats a substantial portion of an earlier “parent” application while adding brand new subject matter or improvements. The U.S. Patent Office has issued a…

TheNewswire • Aug 10, 2026
CTT Pharma Receives SEC Approval

August 5, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the SEC for our S-1 and will now be a SEC reporting company. This is an important milestone as CTT Pharma is now an audited, SEC reporting company on the OTCQB and will start filing an SEC form 8-K when material events occur. CTT will update shareholders as more news becomes…

TheNewswire • Aug 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CTTH.

No House trades found for CTTH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top